David Singer, PharmD, MS

Director, US Health Outcomes
GSK
Philadelphia, Pennsylvania, United States

David Singer, PharmD, MS is Director, US Health Outcomes and Epidemiology at GSK where he is responsible for real-world evidence generation relating to herpes zoster. His research includes prospective and retrospective studies evaluating the clinical and economic burden of herpes zoster as well as economic modeling studies examining the potential impact of vaccination against herpes zoster. Prior to joining GSK, Dr. Singer was an Associate Director, Health Economics and Outcome Research at Boehringer Ingelheim Pharmaceuticals, Inc. where he led health outcomes research and conducted economic analyses relating to specialty medicines and primary care. His research has been published in a number of peer-reviewed journals and presented at various professional conferences.

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• Herpes Zoster: Burden of Disease in Patients at Increased Risk

  Friday, October 21, 2022
  10:15 AM – 11:00 AM US ET